Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk
Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction. Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global...